Influence of social networks on cancer survivors' self-management support: A mixed methods study.


Journal

European journal of cancer care
ISSN: 1365-2354
Titre abrégé: Eur J Cancer Care (Engl)
Pays: England
ID NLM: 9301979

Informations de publication

Date de publication:
May 2022
Historique:
revised: 01 02 2022
received: 27 10 2021
accepted: 02 03 2022
pubmed: 14 4 2022
medline: 11 5 2022
entrez: 13 4 2022
Statut: ppublish

Résumé

The role of social networks, especially weaker ties (e.g. casual acquaintances and hobby groups), in self-management of long-term consequences of cancer is unexplored. This study aimed to explore the structure of cancer survivors' social networks and their contribution to self-management support and health-related quality of life (HRQoL). The study used a sequential, exploratory mixed methods design. Phase 1 surveyed 349 lymphoma, colorectal, breast and prostate cancer survivors. Phase 2 analysed 20 semi-structured interviews with respondents recruited from Phase 1. Phase 1 results suggested participants' HRQoL increased if they participated in an exercise group, if their self-management skills increased, and social distress and negative illness perception decreased (p < 0.0005 adj. R This study suggests engagement with community groups, particularly those not directly related to illness management and social interaction with weak ties, make a valuable contribution to self-management support, increase HRQoL and enhance well-being.

Identifiants

pubmed: 35416341
doi: 10.1111/ecc.13578
pmc: PMC9286412
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e13578

Subventions

Organisme : Health Education England (HEE)/National Institute for Health Research (NIHR)
ID : NIHR CDRF-2013-04-029
Organisme : St. Bartholomew's League of Nurses

Informations de copyright

© 2022 The Authors. European Journal of Cancer Care published by John Wiley & Sons Ltd.

Références

Patient Educ Couns. 2007 May;66(2):192-201
pubmed: 17320338
Soc Sci Med. 1991;33(2):177-83
pubmed: 1887281
Curr Opin Support Palliat Care. 2019 Sep;13(3):225-237
pubmed: 31246595
Support Care Cancer. 2006 Feb;14(2):185-92
pubmed: 16007454
Eur J Oncol Nurs. 2015 Apr;19(2):120-8
pubmed: 25497067
BJU Int. 2021 Dec;128 Suppl 3:18-29
pubmed: 32627306
J Cancer Surviv. 2010 Dec;4(4):372-80
pubmed: 20652435
Psychooncology. 2011 Jan;20(1):36-43
pubmed: 20186841
Acad Med. 2014 Sep;89(9):1245-51
pubmed: 24979285
Health Expect. 2019 Apr;22(2):173-182
pubmed: 30318769
Soc Sci Med. 2015 Jan;125:116-28
pubmed: 24525260
Cancer. 2017 Apr 1;123(7):1228-1237
pubmed: 27943274
J Health Commun. 2015;20(6):656-62
pubmed: 25978562
Cancer. 2014 Oct 15;120(20):3228-36
pubmed: 24988944
SSM Popul Health. 2018 Dec 11;7:100337
pubmed: 30623011
Science. 1988 Jul 29;241(4865):540-5
pubmed: 3399889
J Clin Oncol. 2006 Mar 1;24(7):1105-11
pubmed: 16505430
PLoS One. 2014 Jun 02;9(6):e98340
pubmed: 24887107
Br J Cancer. 2012 Sep 25;107(7):1195-202
pubmed: 22892390
Leuk Lymphoma. 2013 Feb;54(2):290-7
pubmed: 22799432
N Engl J Med. 2007 Jul 26;357(4):370-9
pubmed: 17652652
Support Care Cancer. 2017 Jul;25(7):2063-2073
pubmed: 28197848
Oncol Nurs Forum. 2010 Jul;37(4):484-93
pubmed: 20591808
BMC Med Res Methodol. 2013 Sep 18;13:117
pubmed: 24047204
Eur J Cancer Care (Engl). 2022 May;31(3):e13578
pubmed: 35416341
Breast Cancer Res Treat. 2013 Jun;139(2):515-27
pubmed: 23657404
J Health Serv Res Policy. 2008 Apr;13(2):92-8
pubmed: 18416914
PLoS One. 2016 Aug 18;11(8):e0161027
pubmed: 27536988
Implement Sci. 2014 Feb 13;9:19
pubmed: 24524253
Cancer Nurs. 2020 Jan/Feb;43(1):78-85
pubmed: 30148729
J Psychosom Res. 2006 Jun;60(6):631-7
pubmed: 16731240
Eur J Oncol Nurs. 2013 Dec;17(6):788-96
pubmed: 23587632
Am J Epidemiol. 1979 Feb;109(2):186-204
pubmed: 425958
Support Care Cancer. 2013 Aug;21(8):2153-9
pubmed: 23475196
Qual Life Res. 2005 May;14(4):1007-23
pubmed: 16041897
PLoS One. 2015 Nov 06;10(11):e0141766
pubmed: 26545122
Psychoneuroendocrinology. 2014 Apr;42:38-44
pubmed: 24636499
PLoS One. 2013;8(4):e59723
pubmed: 23565162
Cancer Nurs. 2018 Nov/Dec;41(6):E32-E40
pubmed: 28953505
J Clin Oncol. 1993 Mar;11(3):570-9
pubmed: 8445433
Health Expect. 2018 Feb;21(1):336-346
pubmed: 29024284
J Cancer Surviv. 2016 Apr;10(2):291-301
pubmed: 26202538
Cancer. 2018 Feb 15;124(4):833-840
pubmed: 29160897
Clin Oncol (R Coll Radiol). 2015 Nov;27(11):640-6
pubmed: 26047887
Eur J Cancer Care (Engl). 2017 Nov;26(6):
pubmed: 28004448

Auteurs

Gilly Howard-Jones (G)

Department of Health Sciences, University of Southampton, Southampton, UK.
Maggie's Cancer Support Centre Southampton, University Hospital Southampton, Southampton, UK.

Ivaylo Vassilev (I)

Department of Health Sciences, University of Southampton, Southampton, UK.

Debora Fenlon (D)

Department of Health Sciences, University of Southampton, Southampton, UK.

Sean Ewings (S)

Department of Medical Statistics, University of Southampton, Southampton, UK.

Alison Richardson (A)

University of Southampton & University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH